Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Other Operating Expenses (2017 - 2019)

Mimedx (MDXG) has disclosed Other Operating Expenses for 3 consecutive years, with $2.3 million as the latest value for Q4 2019.

  • Quarterly Other Operating Expenses rose 841.35% to $2.3 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Sep 2020, up 190.11% year-over-year, with the annual reading at -$8.2 million for FY2020, N/A changed from the prior year.
  • Other Operating Expenses hit $2.3 million in Q4 2019 for Mimedx, up from -$2.3 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $2.3 million in Q4 2019 to a low of -$2.3 million in Q3 2019.
  • Historically, Other Operating Expenses has averaged -$231000.0 across 3 years, with a median of -$312000.0 in 2018.
  • Biggest YoY gain for Other Operating Expenses was 841.35% in 2019; the steepest drop was 2377.78% in 2019.
  • Year by year, Other Operating Expenses stood at -$1.0 million in 2017, then surged by 68.8% to -$312000.0 in 2018, then skyrocketed by 841.35% to $2.3 million in 2019.
  • Business Quant data shows Other Operating Expenses for MDXG at $2.3 million in Q4 2019, -$2.3 million in Q3 2019, and -$312000.0 in Q4 2018.